Stoke Therapeutics Inc XNAS: STOK

Mid-range Performer

Download real time

27.30 0.79 (2.98%)

29.44% Fall from 52W High

575.5K

XNAS Volume

XNAS 17 Nov, 2025 2:02 PM (EST)

Stoke Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents